Medication noncompliance

1997 ◽  
Vol 21 (73) ◽  
pp. 39-49
Author(s):  
Mark Olfson ◽  
Stephen Hansell ◽  
Carol A. Boyer
Keyword(s):  
Medication Noncompliance

Medication noncompliance: another iceberg???s tip

2004 ◽  
Vol 77 (5) ◽  
pp. 776-778 ◽  
Author(s):  
Thomas E. Nevins ◽  
Arthur J. Matas
Keyword(s):  
Medication Noncompliance

Disparities and Challenges in Adherence to Oral Antineoplastic Agents

2013 ◽  
pp. 271-276 ◽  
Author(s):  
Melissa K. Accordino ◽  
Dawn L. Hershman
Keyword(s):  
Breast Cancer ◽  
Side Effects ◽  
Health Beliefs ◽  
Hormonal Therapy ◽  
Young Patients ◽  
System Level ◽  
Adjuvant Hormonal Therapy ◽  
Treatment Technology ◽  
Financial Barriers ◽  
Medication Noncompliance

The issue of medication noncompliance is becoming increasingly important in oncology as more cancer therapies are delivered orally. Medication adherence is difficult to assess and there is no gold standard of measurement. The act of measuring adherence can affect outcomes. Medication noncompliance is common, and is estimated to be 50% in treatment of chronic diseases. Studies have shown that women initiate adjuvant hormonal therapy for breast cancer 64% to 88% of the time when prescribed. Of those who initiate therapy, 50% to 80% are adherent for the prescribed duration, depending on the study. Patients noncompliant with adjuvant hormonal therapy for breast cancer have worse overall survival than their counterparts. Suboptimal treatment responses in chronic myeloid leukemia (CML) are also associated with medication noncompliance. Poor adherence can also affect clinical trial results, leading to inaccuracies of treatment efficacy. Barriers to compliance can occur on the individual, cultural, or system level. Examples of specific barriers are side effects, cost and access to medication, and individual health beliefs. Specific populations, including racial minorities, elderly patients, and very young patients, may be at higher risk for medication noncompliance. Strategies to improve compliance are multifactorial and include improvement of patient education, reduction of treatment side effects, interventions to alter behavior, and changes in public policy to improve financial barriers to treatment. Technology has been an effective tool in improving compliance in noncancer-related illness, and ongoing studies are evaluating its role in the oncology population.

Predicting Medication Noncompliance After Hospital Discharge Among Patients With Schizophrenia

2000 ◽  
Vol 51 (2) ◽  
pp. 216-222 ◽  
Author(s):  
Mark Olfson ◽  
David Mechanic ◽  
Stephen Hansell ◽  
Carol A. Boyer ◽  
James Walkup ◽  
...  
Keyword(s):  
Hospital Discharge ◽  
Medication Noncompliance

scholarly journals Spinal Coccidioidomycosis: A Complication From Medication Noncompliance

Cureus ◽  
2020 ◽  
Author(s):  
Surav M Sakya ◽  
Judy P Sakya ◽  
David R Hallan ◽  
Irfan Warraich
Keyword(s):  
Medication Noncompliance

scholarly journals Noncompliance to Diet and Medication among Patients with Type 2 Diabetes Mellitus in Selected Hospitals of Kathmandu, Nepal

2018 ◽  
Vol 06 (02) ◽  
pp. 090-095
Author(s):  
Nisha Kafle ◽  
Resham Poudel ◽  
Sushan Shrestha
Keyword(s):  
Diabetes Mellitus ◽  
Type 2 Diabetes ◽  
Type 2 Diabetes Mellitus ◽  
Medication Adherence ◽  
Public Hospitals ◽  
Private Hospitals ◽  
Public And Private ◽  
Medication Noncompliance ◽  
Public And Private Hospitals

Abstract Background Diabetes is a major public health problem affecting people of all ages globally. Noncompliance compromises the effectiveness of treatment and adversely affects patients' health. The main purpose of this study was to assess and compare the proportion of noncompliance to diet and medication between patients with type 2 diabetes mellitus (T2DM) visiting public and private hospitals in Kathmandu, Nepal. Methods Descriptive cross-sectional study was conducted in T2DM patients visiting public and private hospitals. Eight item Morisky Medication Adherence Questionnaire (MMAQ) for medication adherence and Perceived Dietary Adherence Questionnaire (PDAQ) for dietary adherence were used. Epidata was used for data entry and SPSS for data analysis. Chi-square test was used as a test of significance. Odds ratio (OR) and the corresponding 95% confidence intervals (CI) were calculated. Results The study involved 182 T2DM patients. Participants' age was ≥ 17 years and they were under treatment for ≥ 6 months. Mean age of the participants was 54.67 years with standard deviation (SD) ± 11.69. Prevalence of medication noncompliance was seen in 126 (69.2%) patients, whereas prevalence of dietary noncompliance was seen in 166 (91.2%) patients. Illiterate participants were more likely to be noncompliant than literate to medication (OR 4.32, p = 0.001). Self-employed were more likely to be noncompliant to medication than job holders (OR 2.93, p = 0.008). People visiting public hospital were more likely to be noncompliant to diet than those visiting private hospital (OR 4.89, p = 0.009). Illiterate participants were more likely to be noncompliant to diet than literate (OR 10.94, p = 0.005). Conclusion The T2DM patients visiting public hospitals were more noncompliant to diet. Illiterate patients were more noncompliant to both medication and diet. Self-employed compared with job holders were more noncompliant to medication. Patient education and counseling should be aggressively addressed mainly in public hospitals. There was no significant difference in medication noncompliance between public and private hospitals (p = 0.108).

Sign in / Sign up

Export Citation Format

Share Document